Miscellaneous News

Eventine

Junior Member
Registered Member
There used to be a belief that once China displays more of their advances and express willingness to do big projects like James Webb they will be collaboration. That's not true at all. Further advances in Chinese space technology will further this tension, not increase the likelihood of cooperation.

Wolf has been supported by every Adminstration since 2011 (Bill Nelson just recently voted to keep the Wolf Amendments). You can cite human rights or IP concerns but the truth is while there are some scientists in NASA and other US colleges that want partnerships with China in certain areas such as astronomy, from a couple of my old jobs I can confirm the overwhelming majority of people there and subcontractors that support them do not want any collaboration and they absolute see it as a space race.

No Chinese astronauts has ever visited the ISS and I have no doubt that this will extend towards projects on the lunar surface in the 2030s.
Chinese should get off this public image of constantly asking for cooperation & collaboration. They should publicly embrace the competition with the West and slogan it up. The Global South respects strength above all.
 

tokenanalyst

Brigadier
Registered Member
Chinese should get off this public image of constantly asking for cooperation & collaboration. They should publicly embrace the competition with the West and slogan it up. The Global South respects strength above all.
China should working in advancing their science/tech forward for the benefit of humanity and their country and don't give a crap about what some stooges clowns in the US and their lapdogs think. I they want collaboration, collaborate and they don't, the hell with them.
 

Petrolicious88

Senior Member
Registered Member
What "they"??

If you mean by drug producers, regulators will rape whichever med companies try to price gouge, but glp1 analogues has been a thing since forever, and demand simply hasn't been be the high it was it in US because most Chinese aren't that fat.

There won't be a glp1 boom in China, if there could be, it would have been years ago. Ppl will still take it, but there aren't that many mega obese.
It’s already booming. Blame it on social media and celebrity endorsements. Most of that demand will come from treating obesity not diabetes.

Take a pill to lose 10-30lbs. Yea, plenty of Chinese women would want that even though by western standards they are not as obese. Why be 130lbs when you can be 110.
 

supersnoop

Major
Registered Member
Please, Log in or Register to view URLs content!

Please, Log in or Register to view URLs content!

They going to limit the supplies to China cause the demand will be through the roof. Never remember seeing obesity in China that much until McDonald’s came to town.

Btw not too long ago this used to be science fiction. Take a pill and drop 20-30lbs with no changes in lifestyle or diet.
Semaglutide is an appetite suppressant, so literally it changes your diet
 

supersnoop

Major
Registered Member
It’s already booming. Blame it on social media and celebrity endorsements. Most of that demand will come from treating obesity not diabetes.

Take a pill to lose 10-30lbs. Yea, plenty of Chinese women would want that even though by western standards they are not as obese. Why be 130lbs when you can be 110.
Adding to this...
As an appetite suppressant, semaglutide's effects would likely be less pronounced on someone who is already lower in weight.
Someone who is 200 lb is probably eating way in excess to begin with, someone who is 130, less so.
Plus weight loss is not linear.

These factors can greatly affect the popularity.
 

Index

Junior Member
Registered Member
It’s already booming. Blame it on social media and celebrity endorsements. Most of that demand will come from treating obesity not diabetes.

Take a pill to lose 10-30lbs. Yea, plenty of Chinese women would want that even though by western standards they are not as obese. Why be 130lbs when you can be 110.
Well yeah to some extent but medical companies have also been continously obliged to keep selling them for relatively cheap.

There has been a business since for as long they've existed, but it's not going to be as huge as in US. And it's hardly a novel thing.

A healthy weight person is likely better served taking bupropion if they want to further go down in weight than glp1 analog. The latter suppresses appetite and would probably not be too helpful in achieving 130ib->110ib, since the 130ib person isn't overeating.
 

Petrolicious88

Senior Member
Registered Member
Well yeah to some extent but medical companies have also been continously obliged to keep selling them for relatively cheap.

There has been a business since for as long they've existed, but it's not going to be as huge as in US. And it's hardly a novel thing.

A healthy weight person is likely better served taking bupropion if they want to further go down in weight than glp1 analog. The latter suppresses appetite and would probably not be too helpful in achieving 130ib->110ib, since the 130ib person isn't overeating.
Sored in popularity recently because of off label use for weight loss. Nothing new for diabetes.

A good amt of people taking it these days are not diabetic.

Wellbutrin vs. Ozempic. Messing with your dopamine or GLP-1. Don’t know what’s worse. Some patients actually get increased appetite from Wellbutrin.

Anyway, because of its popularity in the West, along with increase in western diet/lifestyle in China, demand for Ozempic set to skyrocket. Taobao sells it for $138 a pop(due to demand), twice the price from public hospitals.
 

Index

Junior Member
Registered Member
Sored in popularity recently because of off label use for weight loss. Nothing new for diabetes.

A good amt of people taking it these days are not diabetic.

Wellbutrin vs. Ozempic. Messing with your dopamine or GLP-1. Don’t know what’s worse. Some patients actually get increased appetite from Wellbutrin.

Anyway, because of its popularity in the West, along with increase in western diet/lifestyle in China, demand for Ozempic set to skyrocket. Taobao sells it for $138 a pop(due to demand), twice the price from public hospitals.
Demand already rocketed up along the first wave of off label use.
 
Top